Intra-Cellular: Johnson & Johnson Set To Complete Acquisition Of Intra-Cellular Therapies By April 2, 2025
(RTTNews) - Johnson & Johnson (JNJ) announced that following the approval of its pending acquisition of Intra-Cellular Therapies by Intra-Cellular Therapies' shareholders on March 27, 2025, Johnson & Johnson plans to complete its acquisition of Intra-Cellular Therapies on or aro
Read full article »
Intra-Cellular Therapies is a New York-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of central nervous system disorders.
Read more